Daxor Corporation Common Stock (DXR)
Daxor Corporation (DXR) is a medical device company specializing in blood volume measurement technology. It is known for its BVA-100 Blood Volume Analyzer, which provides precise blood volume readings to aid in the diagnosis and management of various health conditions, including anemia, heart failure, and blood disorders. The company has a long-standing history of developing and commercializing innovative diagnostic tools within the healthcare industry.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| January 12, 2018 | $0.03 | 2018-01-05 | 2018-01-08 |
| December 29, 2016 | $0.03 | 2016-12-20 | 2016-12-22 |
| December 29, 2015 | $0.04 | 2015-12-18 | 2015-12-22 |
| December 26, 2014 | $0.03 | 2014-12-04 | 2014-12-08 |
| December 27, 2013 | $0.05 | 2013-12-05 | 2013-12-09 |
Dividends Summary
- Daxor Corporation Common Stock has issued 18 dividend payments over the past 10 years
- The most recent dividend was paid 2825 days ago, on January 12, 2018
- The highest dividend payed out to investors during this period was $1.00 per share
- The average dividend paid during this period was $0.25 per share.
Company News
Daxor Corporation, a leader in blood volume measurement technology, will showcase its innovative Blood Volume Analysis (BVA) at the MedAxiom Cardiovascular Transforum Spring 2025 conference. WellStar Health System will present findings on how BVA-driven strategies significantly reduced kidney injury following LVAD implantation.
Gainers Greenhill & Co., Inc. (NYSE: GHL) shares jumped 116.4% to $14.67 after Mizuho announced it would acquire the company for $15 per share. AVROBIO, Inc. (NASDAQ: AVRO) gained 93.5% to $1.50 after the company announced it would sell its gene therapy program to Novartis for $87.5 million. Microbot Medical Inc. (NASDAQ: MBOT) rose 66% to $2.04...